Inferring Influenza Infection Attack Rate from Seroprevalence Data

PLoS Pathogens

Volumn 10, Issue 4, 2014, Pages

  Wu, Joseph T ^a   Leung, Kathy ^a   Perera, Ranawaka A P M ^a   Chu, Daniel K W ^a   Lee, Cheuk Kwong ^b   Hung, Ivan F N ^a   Lin, Che Kit ^b   Lo, Su Vui ^c,d   Lau, Yu Lung ^a   Leung, Gabriel M ^a   Cowling, Benjamin J ^a   Peiris, J S Malik ^a,e  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b HOSPITAL AUTHORITY   (Hong Kong)

^c Hospital Authority   (Hong Kong)

^d Food and Health Bureau   (Hong Kong)

^e HKU PASTEUR RESEARCH CENTRE   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY RESPONSE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DISEASE SEVERITY; DISEASE TRANSMISSION; HEALTH SURVEY; HOSPITALIZATION; HOST SUSCEPTIBILITY; HUMAN; IMMUNITY; INFLUENZA; INFLUENZA VIRUS A H1N1; INFORMATION PROCESSING; MORBIDITY; NONHUMAN; PATHOGENESIS; RISK FACTOR; SEROPREVALENCE; ADOLESCENT; ADULT; BIOLOGICAL MODEL; CLINICAL TRIAL; EPIDEMIOLOGY; HONG KONG; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PANDEMIC; PRESCHOOL CHILD;

ADOLESCENT; ADULT; CHILD, PRESCHOOL; HONG KONG; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PANDEMICS; SEROEPIDEMIOLOGIC STUDIES;

EID: 84901293079     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1004054     Document Type: Article

References (38)

1. Van Kerkhove MD, Asikainen T, Becker NG, Bjorge S, Desenclos J-C, et al. (2010) Studies Needed to Address Public Health Challenges of the 2009 H1N1 Influenza Pandemic: Insights from Modeling. PLoS Med 7: e1000275.
2. Lipsitch M, Finelli L, Heffernan RT, Leung GM, Redd SC, et al. (2011) Improving the evidence base for decision making during a pandemic: the example of 2009 influenza A/H1N1. Biosecurity and bioterrorism: biodefense strategy, practice, and science 9: 89-115.
3. Fineberg HV, Aavitsland P, Aditama T, Bino S, Carmo EH, et al. (2011) Implementation of the international health regulations (2005): report of the Review Committee on the Functioning of the International Health Regulations (2005) and on Pandemic Influenza A(H1N1) 2009. Geneva: World Health Organization.
4. Broberg E, Nicoll A, Amato-Gauci A, (2011) Seroprevalence to influenza A(H1N1) 2009 virus-where are we? Clin Vaccine Immunol 18: 1205-1212.
5. Van Kerkhove MD, Hirve S, Koukounari A, Mounts AW, (2013) Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries. Influenza and Other Respiratory Viruses 7: 872-886.
6. Bandaranayake D, Huang QS, Bissielo A, Wood T, Mackereth G, et al. (2010) Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic. PLoS ONE 5: e13211.
7. Chen MI, Barr IG, Koh GCH, Lee VJ, Lee CPS, et al. (2010) Serological Response in RT-PCR Confirmed H1N1-2009 Influenza A by Hemagglutination Inhibition and Virus Neutralization Assays: An Observational Study. PLoS ONE 5: e12474.
8. Dudareva S, Schweiger B, Thamm M, Höhle M, Stark K, et al. (2011) Prevalence of Antibodies to 2009 Pandemic Influenza A (H1N1) Virus in German Adult Population in Pre- and Post-Pandemic Period. PLoS ONE 6: e21340.
9. McVernon J LK, Nolan T, Owen R, Irving D, Capper H, et al. (2010) Seroprevalence of 2009 pandemic influenza A(H1N1) virus in Australian blood donors, October- December, 2009. Eurosurveillance 15: pii = 19678.
10. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, et al. (2010) Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. The Lancet 375: 1100-1108.
11. Wu JT, Ma ESK, Lee CK, Chu DKW, Ho P-L, et al. (2010) The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong. Clinical Infectious Diseases 51: 1184-1191.
12. Baguelin M, Hoschler K, Stanford E, Waight P, Hardelid P, et al. (2011) Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation. PLoS ONE 6: e17074.
13. Wu JT, Ho A, Ma ESK, Lee CK, Chu DKW, et al. (2011) Estimating Infection Attack Rates and Severity in Real Time during an Influenza Pandemic: Analysis of Serial Cross-Sectional Serologic Surveillance Data. PLoS Med 8: e1001103.
14. Cox CM, Goodin K, Fisher E, Dawood FS, Hamilton JJ, et al. (2011) Prevalence of 2009 pandemic influenza A (H1N1) virus antibodies, Tampa Bay Florida-November-December, 2009. PLoS ONE 6: e29301.
15. Reed C, Katz JM, Hancock K, Balish A, Fry AM, et al. (2012) Prevalence of Seropositivity to Pandemic Influenza A/H1N1 Virus in the United States following the 2009 Pandemic. PLoS ONE 7: e48187.
16. Hens N, Shkedy Z, Aerts M, Faes C, Van Damme P, et al. (2012) Modeling Infectious Disease Parameters Based on Serological and Social Contact Data: Springer. 298 p.
17. Steens A, Waaijenborg S, Teunis PFM, Reimerink JHJ, Meijer A, et al. (2011) Age-Dependent Patterns of Infection and Severity Explaining the Low Impact of 2009 Influenza A (H1N1): Evidence From Serial Serologic Surveys in the Netherlands. American Journal of Epidemiology 174: 1307-1315.
18. Hardelid P, Williams D, Dezadeux C, Tookey PA, Peckham CS, et al. (2008) Analysis of rubella antibody distribution from newborn dried blood spots using finite mixture models. Epidemiology & Infection 136: 1698-1706.
19. Vyse AJ, Andrews NJ, Hesketh LM, Pebody R, (2007) The burden of parvovirus B19 infection in women of childbearing age in England and Wales. Epidemiology & Infection 135: 1354-1362.
20. Cowling BJ, Lau MSY, Ho L-M, Chuang S-K, Tsang T, et al. (2010) The Effective Reproduction Number of Pandemic Influenza: Prospective Estimation. Epidemiology 21: 842-846 810.1097/EDE.1090b1013e3181f20977.
21. Wu JT, Cowling BJ, Lau EHY, Ip DKM, Ho L-M, et al. (2010) School Closure and Mitigation of Pandemic (H1N1) 2009, Hong Kong. Emerging Infectious Diseases 16: 538-541.
22. Wu JT, Ma ESK, Lee CK, Chu DKW, Ho PL, et al. (2010) The infection attack rate and severity of 2009 pandemic influenza (H1N1) in Hong Kong. Clinical Infectious Diseases 51: 1184-1191.
23. Hung IFN, To KKW, Lee C-K, Lin C-K, Chan JFW, et al. (2010) Effect of Clinical and Virological Parameters on the Level of Neutralizing Antibody against Pandemic Influenza A Virus H1N1 2009. Clinical Infectious Diseases 51: 274-279.
24. Veguilla V, Hancock K, Schiffer J, Gargiullo P, Lu X, et al. (2011) Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. Populations. Journal of Clinical Microbiology 49: 2210-2215.
25. Cowling BJ, Chan KH, Fang VJ, Lau LLH, So HC, et al. (2010) Comparative Epidemiology of Pandemic and Seasonal Influenza A in Households. New England Journal of Medicine 362: 2175-2184.
26. Mossong J, Hens N, Jit M, Beutels P, Auranen K, et al. (2008) Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases. PLoS Med 5: e74.
27. Boëlle P-Y, Ansart S, Cori A, Valleron A-J, (2011) Transmission parameters of the A/H1N1 (2009) influenza virus pandemic: a review. Influenza and Other Respiratory Viruses 5: 306-316.
28. Cauchemez S, Donnelly CA, Reed C, Ghani AC, Fraser C, et al. (2009) Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus in the United States. New England Journal of Medicine 361: 2619-2627.
29. Cauchemez S, Bhattarai A, Marchbanks TL, Fagan RP, Ostroff S, et al. (2011) Role of social networks in shaping disease transmission during a community outbreak of 2009 H1N1 pandemic influenza. Proceedings of the National Academy of Sciences 108: 2825-2830.
30. Hardelid P, Andrews N, Hoschler K, Stanford E, Baguelin M, et al. (2010) Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1. Health Technology Assessment 14: 115-192.
31. Papenburg J, Baz M, Hamelin M-È, Rhéaume C, Carbonneau J, et al. (2011) Evaluation of Serological Diagnostic Methods for the 2009 Pandemic Influenza A (H1N1) Virus. Clinical and Vaccine Immunology 18: 520-522.
32. Wood JM, Gaines-Das RE, Taylor J, Chakraverty P, (1994) Comparison of influenza serological techniques by international collaborative study. Vaccine 12: 167-174.
33. Mak GC, Choy PWW, Lee WY, Wong AH, Ng KC, et al. (2010) Sero-immunity and serologic response to pandemic influenza A (H1N1) 2009 virus in Hong Kong. Journal of Medical Virology 82: 1809-1815.
34. Tu W, Mao H, Zheng J, Liu Y, Chiu SS, et al. (2010) Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus. Journal of virology 84: 6527-6535.
35. Tang JW, Ngai KL, Lam WY, Chan PK, (2008) Seasonality of influenza A(H3N2) virus: a Hong Kong perspective (1997-2006). PLoS ONE 3: e2768.
36. Cauchemez S, Horby P, Fox A, Mai le Q, Thanh le T, et al. (2012) Influenza infection rates, measurement errors and the interpretation of paired serology. PLoS Pathog 8: e1003061.
37. Birrell PJ, Ketsetzis G, Gay NJ, Cooper BS, Presanis AM, et al. (2011) Bayesian modeling to unmask and predict influenza A/H1N1pdm dynamics in London. Proceedings of the National Academy of Sciences 108: 18238-18243.
38. Xie X, Lu SQ, Cheng JQ, Cheng XW, Xu ZH, et al. (2012) Estimate of 2009 H1N1 influenza cases in Shenzhen-the biggest migratory city in China. Epidemiol Infect 140: 788-797.